Advertisement

A multi-institutional outcomes analysis of patients with relapsed or refractory DLBCL treated with ibrutinib

Allison M. Winter, Daniel J. Landsburg, Anthony R. Mato, Krista Isaac, Francisco J. Hernandez-Ilizaliturri, Nishitha Reddy, Stephen Smith, Mazyar Shadman, Mitchell R. Smith, Paolo Caimi, Deepa Jagadeesh and Brian T. Hill

Article Information

Citation 
vol. 130 no. 14 1676-1679

Print ISSN 
Online ISSN 
History 
  • Published online October 5, 2017.

Article Versions


Contributors 
  • Allison M. Winter, 1Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;
  • Daniel J. Landsburg, 2Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA;
  • Anthony R. Mato, 2Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA;
  • Krista Isaac, 3Department of Internal Medicine, Lankenau Medical Center, Wynnewood, PA;
  • Francisco J. Hernandez-Ilizaliturri, 4Roswell Park Cancer Institute, Buffalo, NY;
  • Nishitha Reddy, 5Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN;
  • Stephen Smith, 6Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA;
  • Mazyar Shadman, 6Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA;
  • Mitchell R. Smith, 7Department of Hematology and Medical Oncology, George Washington University Cancer Center, Washington, DC; and
  • Paolo Caimi, 8Department of Medicine, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, OH
  • Deepa Jagadeesh, 1Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;
  • Brian T. Hill, 1Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output